<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="publisher-id">eins</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
        <publisher-loc>Sao Paulo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24488398</article-id>
      <article-id pub-id-type="pmc">4880396</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082013000400023</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082013000400023</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>S&#xED;ndrome de opsoclonia-mioclonia-ataxia em paciente com AIDS</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vale</surname>
            <given-names>Thiago Cardoso</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Rodrigo Alencar e</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cunningham</surname>
            <given-names>Mauro C&#xE9;sar Quint&#xE3;o e Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maia</surname>
            <given-names>D&#xE9;bora Palma</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Camargos</surname>
            <given-names>Sarah Teixeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.</aff>
        <aff id="aff2"><label>2</label>Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Corresponding author: Thiago Cardoso Vale &#x2013; Hospital das Cl&#xED;nicas, Neurologia, Avenida Professor Alfredo Balena, 100, 3rd floor &#x2013; Santa Efig&#xEA;nia &#x2013; Zip code: 30130-100 &#x2013; Belo Horizonte, MG, Brazil &#x2013; Phone: <phone>(55 31) 3409-9417</phone> &#x2013; E-mail: <email>thiago.vale@ufjf.edu.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2013</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>11</volume>
      <issue>4</issue>
      <fpage>533</fpage>
      <lpage>534</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <p>We report the case of a 38-year-old woman with AIDS who developed opsoclonus-myoclonus-ataxia syndrome during a period different from other cases reported in literature. Opsoclonus-myoclonus-ataxia syndrome had already been reported as the initial neurological presentation of AIDS, as well as at the time of HIV-seroconversion and immune reconstitution syndrome. Our case is unique since the patient had an elevated CD4 count and negative viral load in the period when the opsoclonus-myoclonus-ataxia syndrome occurred.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <title>RESUMO</title>
        <p>&#xC9; relatado aqui o caso de uma mulher de 38 anos com AIDS que desenvolveu a s&#xED;ndrome de opsoclonia-mioclonia-ataxia em um per&#xED;odo diferente dos outros casos j&#xE1; relatados na literatura. A s&#xED;ndrome de opsoclonia-mioclonia-ataxia j&#xE1; tinha sido relatada como manifesta&#xE7;&#xE3;o inicial de AIDS, assim como no momento da soroconvers&#xE3;o de HIV e na s&#xED;ndrome de reconstitui&#xE7;&#xE3;o imune. Este caso &#xE9; &#xFA;nico, uma vez que a paciente tinha contagem elevada de CD4 e carga viral negativa no momento em que a s&#xED;ndrome de opsoclonia-mioclonia-ataxia ocorreu.</p>
      </trans-abstract>
      <kwd-group>
        <title>Keywords:</title>
        <kwd>Ocular motility disorders</kwd>
        <kwd>Ataxia</kwd>
        <kwd>Myoclonus</kwd>
        <kwd>Ataxic gait</kwd>
        <kwd>HIV</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="5"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Opsoclonus-myoclonus-ataxia syndrome (OMAS) is characterized by continuous multidirectional saccadic eye movements accompanied by generalized myoclonus and, less frequently, cerebellar ataxia, postural tremor, encephalopathy, and behavioral disturbances. It is also known as &#x201C;dancing eye and dancing feet syndrome&#x201D;<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>. Although most cases of OMAS are paraneoplastic (typically associated with breast and small cell lung cancers), toxic-metabolic, or idiopathic, some are post-infectious. There have been reports of this syndrome in patients with AIDS after seroconversion and as part of an immune reconstitution syndrome<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup>. To the best of our knowledge, we present the first case of OMAS in a patient with AIDS without criteria for both previous scenarios of the course of the infection.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 38-year-old woman had a history of schizophrenia for the past 16 years and AIDS since she was 30 years old. She was on haloperidol and levomepromazine since the psychiatric diagnosis, as well as highly active antiretroviral therapy (HAART) comprised of lamivudine, tenofovir, and ritonavir-boosted atazanavir. She was diagnosed as AIDS patient in 2002 after presenting with recurrent pneumonia, sinusitis, and two episodes of herpes-zoster infection. In 2004, she received the first HAART scheme after a CD4+ count of only 39 cells/mm<sup>3</sup>. Initially, the patient did not comply with treatment, resulting in a CD4+ count of 13 cells/mm<sup>3</sup> in 2005 and prompting a new HAART scheme. Her CD4+ count gradually raised and resulted in a negative viral load at the beginning of 2006. In April 2010, with a CD4+ count of 537 cells/mm<sup>3</sup> and a negative viral load, the patient presented with vomiting, headache, a wide-base unsteady gait, bradykinesia, rigidity, facial hypomimia and mild uncontrolled jerky movements of the eyes, head, and fingers of both hands. She was diagnosed with OMAS and drug-induced parkinsonian syndrome. Cranial computed tomography was normal and brain magnetic resonance imaging revealed nonspecific white matter abnormalities in periventricular areas, cerebellar hemispheres, left temporal lobe, and thalamus (<xref ref-type="fig" rid="f1">Figure 1</xref>). Cerebrospinal fluid (CSF) analysis showed lymphocytic pleocytosis (22 leukocytes/mm<sup>3</sup> with 95% of lymphocytes), 43mg/dL of proteins, and 49mg/dL of glucose. CSF <italic>Gram</italic> stain, cultures, and VDRL were negative. Latex-cryptococcus antigen test and polymerase chain reaction (PCR) for tuberculosis and herpes-simplex virus were negative. Serum protozoan and viral IgM serologies (toxoplasmosis, cytomegalovirus, and herpes-simplex virus) were also negative. She was treated with clonazepam with gradual improvement of vomiting, headache, ataxia, and opsoclonus, but persistence of distal myoclonus in the upper limbs.</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <title>Contrasted T1-weighted magnetic resonance imaging sequence showing nonspecific hyperintensities in cerebellar hemispheres (red arrows)</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-11-04-0533-gf01"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>There are less than a handful of case reports on OMAS occurring in HIV-patients<sup>(<xref rid="B3" ref-type="bibr">3</xref>&#x2013;<xref rid="B5" ref-type="bibr">5</xref>)</sup>. All cases were reported in four different stages of HIV-infection: three cases as the initial neurological presentation, two cases at the time of HIV-seroconversion, two cases as part of the immune reconstitution syndrome, and one case at the time of tuberculosis reactivation. Our case is unique since the patient had elevated CD4 count and negative viral load in the period when OMAS occurred.</p>
      <p>The mechanism underlying the pathogenesis of OMAS remains to be determined. Notwithstanding, robust evidence supports an autoimmune basis for OMAS affecting the brainstem, the pontine paramedian reticular formation, and cerebellar circuits<sup>(<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>. A humoral immune mechanism could be suggested by the response of OMAS to immune therapy in a few patients and by the detection of autoantibodies. Zandman-Goddard et al.<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> showed that patients with HIV with stable CD4+ counts are more prone to having autoimmune conditions than the general population, and often have a range of autoantibodies even when asymptomatic. On the other hand, due to absence of specific autoantibodies in all OMAS cases and the inability to passively transfer OMAS to animals, involvement of humoral immunity is less probable, suggesting the role of cell-mediated immunity. HIV-associated OMAS may be the consequence of an imbalance inflammation in which a reduced CD4/CD8 ratio, in addition to a critical level of functional CD4+ cells for efficient CD8+ cytotoxicity, results in dysfunction of brainstem-cerebellar circuitry in susceptible individuals<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>. OMAS may improve spontaneously when mild, or require immune therapy when symptoms are persistent. Due to the difficulties of using immunosuppressive therapy in HIV+ patients and the lesser severity of her OMAS, she was treated with benzodiazepines. The patient improved rather quickly, but persisted with distal myoclonus.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>This is a case report of an AIDS patient who developed OMAS in a particular period of the infection not previously reported in the literature.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>An update on opsoclonus</article-title>
          <source>Curr Opin Neurol</source>
          <year>2007</year>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">17215685</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanjanasut</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Phanthumchinda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bhidayasiri</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases</article-title>
          <source>Clin Neurol Neurosurg</source>
          <year>2010</year>
          <volume>112</volume>
          <issue>7</issue>
          <fpage>572</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">20427123</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Heckmann</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Opsoclonus-myoclonus syndrome and HIV-infection</article-title>
          <source>J Neurol Sci</source>
          <year>2009</year>
          <volume>284</volume>
          <issue>1&#x2013;2</issue>
          <fpage>192</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">19419738</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>vanToorn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rabie</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Warwick</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome</article-title>
          <source>Eur J Paediatr Neurol</source>
          <year>2005</year>
          <volume>9</volume>
          <issue>6</issue>
          <fpage>423</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">16269259</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zandman-Goddard</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shoenfeld</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>HIV and autoimmunity</article-title>
          <source>Autoimmun Rev</source>
          <year>2002</year>
          <volume>1</volume>
          <issue>6</issue>
          <fpage>329</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="pmid">12848988</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
